Return to Statistics Toolbox

Pathway mapping for Study ST000196

(Analysis All analyses used)
Select one or more experimental factors for Groups 1 and 2. The members of each group should be DIFFERENT.
Group1Experimental factorGroup2
Recovery:five week recovery | Gender:female | Treatment:Cefoperazone treated (3)
Recovery:five week recovery | Gender:male | Treatment:Cefoperazone treated (4)
Recovery:four week recovery | Gender:female | Treatment:Cefoperazone treated (4)
Recovery:four week recovery | Gender:male | Treatment:Cefoperazone treated (3)
Recovery:na | Gender:female | Treatment:No antibiotics (6)
Recovery:na | Gender:male | Treatment:No antibiotics (6)
Recovery:no recovery | Gender:female | Treatment:Cefoperazone treated (5)
Recovery:no recovery | Gender:female | Treatment:IP clindamycin (5)
Recovery:no recovery | Gender:female | Treatment:Kanamycin treated (6)
Recovery:no recovery | Gender:female | Treatment:Metronidazole treated (5)
Recovery:no recovery | Gender:female | Treatment:Vancomycin treated (6)
Recovery:no recovery | Gender:male | Treatment:Cefoperazone treated (5)
Recovery:no recovery | Gender:male | Treatment:IP clindamycin (6)
Recovery:no recovery | Gender:male | Treatment:Kanamycin treated (4)
Recovery:no recovery | Gender:male | Treatment:Metronidazole treated (6)
Recovery:no recovery | Gender:male | Treatment:Vancomycin treated (6)
Recovery:one week recovery | Gender:female | Treatment:Cefoperazone treated (7)
Recovery:one week recovery | Gender:male | Treatment:Cefoperazone treated (5)
Recovery:six week recovery | Gender:female | Treatment:Cefoperazone treated (4)
Recovery:six week recovery | Gender:female | Treatment:Cefoperazone treated IP clindamycin (6)
Recovery:six week recovery | Gender:male | Treatment:Cefoperazone treated (3)
Recovery:six week recovery | Gender:male | Treatment:Cefoperazone treated IP clindamycin (6)
Recovery:three week recovery | Gender:female | Treatment:Cefoperazone treated (5)
Recovery:three week recovery | Gender:male | Treatment:Cefoperazone treated (7)
Recovery:two week recovery | Gender:female | Treatment:Cefoperazone treated (6)
Recovery:two week recovery | Gender:male | Treatment:Cefoperazone treated (6)
Limit by pathway class:
Analysis:Combine data for all analyses?:     

  logo